You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Frequency Basal Cell Carcinomas

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 13, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Missing Tooth Trial in Ann Arbor (Lithium disilicate ceramic (Ivoclar))

Active, not recruiting
  • Missing Tooth
  • Lithium disilicate ceramic (Ivoclar)
  • Ann Arbor, Michigan
    University of Michigan
Sep 6, 2022

Hemodialysis Trial in Grenoble (Biological analysis)

Not yet recruiting
  • Hemodialysis
  • Biological analysis
  • Grenoble, France
    Grenoble University Hospital
May 10, 2022

Hematologic Malignancy, Muscle Weakness Trial in Istanbul (Neuromuscular Electrical Stimulation, Structured Exercise)

Completed
  • Hematologic Malignancy
  • Muscle Weakness
  • Neuromuscular Electrical Stimulation
  • Structured Exercise
  • Istanbul, Turkey
    Acibadem University
May 25, 2022

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

Recruiting
  • Macrophage Activation Syndrome
  • +6 more
  • Birmingham, Alabama
  • +41 more
Jan 3, 2023

Fibrodysplasia Ossificans Progressiva Trial (Garetosmab, Placebo)

Recruiting
  • Fibrodysplasia Ossificans Progressiva
  • Nagoya, Aichi, Japan
  • +1 more
Jan 17, 2023

Femoral Fracture, Tibial Fractures Trial in Lexington, Nashville (Standard of Care Physical Therapy Program, Speed Walking

Recruiting
  • Femoral Fracture
  • Tibial Fractures
  • Standard of Care Physical Therapy Program
  • Speed Walking Intervention
  • Lexington, Kentucky
  • +1 more
May 26, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Tumors Trial in France (Blood and tumor samples)

Recruiting
  • Neoplasms
  • Blood and tumor samples
  • Annecy, France
  • +5 more
Apr 8, 2022

Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

Recruiting
  • Lymphoma
  • PNEUMOVAX 23
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Ovarian Cancer Individualized Scoring System Scoring System

Not yet recruiting
  • Ovarian Cancer
    • Alexandria, Egypt
    • +1 more
    Aug 9, 2022

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023

    HIV, Pregnancy Related, Mother to Child Transmission Trial in Salvador (Dolutegravir plus lamivudine in a FDC)

    Recruiting
    • HIV Infections
    • +2 more
    • Dolutegravir plus lamivudine in a FDC
    • Salvador, BA, Brazil
      Fundação Bahiana de Infectologia
    Feb 3, 2022

    Epithelial Ovarian Cancer: A Retrospective Study

    Recruiting
    • Epithelial Ovarian Cancer
    • Hematologic features
    • Shanghai, Shanghai, China
      Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
    Oct 16, 2023

    Bowel Preparation Before Colonoscopy Trial in Wuhan (PEG+lactulose, CSP+lactulose)

    Recruiting
    • Bowel Preparation Before Colonoscopy
    • Wuhan, Hubei, China
      Renmin Hospital of Wuhan University
    Aug 24, 2022

    Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

    Active, not recruiting
    • Colorectal Cancer
    • IBI310 (anti-CTLA-4 antibody)
    • Sintilimab(anti-PD-1 antibody)
    • Beijing, China
      Beijing cancer hospital
    Sep 15, 2022

    ART, Pre-Eclampsia Trial in France (Aspirin, Placebo)

    Not yet recruiting
    • ART
    • Pre-Eclampsia
    • Angers, France
    • +21 more
    Nov 22, 2022

    Infertility, Female Trial in Changsha (Dexamethasone Oral Tablet)

    Withdrawn
    • Infertility, Female
    • Dexamethasone Oral Tablet
    • Changsha, Hunan, China
      Reproductive & Genetic Hospital of CITIC-XIANGYA
    Jan 10, 2022

    Perineal Tear Trial in Poitiers (Recording of expulsive efforts by connection of a pressure sensor to the women's bladder probe)

    Recruiting
    • Perineal Tear
    • Recording of expulsive efforts by connection of a pressure sensor to the women's bladder probe
    • Poitiers, France
      CHU Poitiers
    Jan 7, 2022

    Obstructive Sleep Apnea Trial (Zolpidem, Placebo)

    Not yet recruiting
    • Obstructive Sleep Apnea
    • (no location specified)
    Oct 9, 2023

    SARS-CoV-2 Disease on Immune Responses, Disease Severity and

    Recruiting
    • COVID-19 Respiratory Infection
    • Pulmonary Tuberculoses
      • Chennai, Tamilnadu, India
        National Institute for Research in Tuberculosis
      Jul 6, 2022

      Aging Trial in Paris (injection, Cream application)

      Completed
      • Aging
      • injection
      • Cream application
      • Paris, France
        Dr Jean-Jacques DEUTSCH
      Nov 7, 2022